2016—Subsec. (b)(1). Pub. L. 114–255, § 2037(a)(1), substituted “phase IIB” for “phase IIA”.
Subsec. (b)(2). Pub. L. 114–255, § 2037(a)(2)(A), substituted “phase III” for “phase IIB” in introductory provisions.
Subsec. (b)(2)(A). Pub. L. 114–255, § 2037(a)(2)(B), substituted “phase III” for “phase IIB”.
Subsec. (b)(2)(B). Pub. L. 114–255, § 2037(a)(2)(C), substituted “phase IIB” for “phase IIA”.
Subsec. (b)(2)(C). Pub. L. 114–255, § 2037(a)(2)(D), substituted “phase III” for “phase IIB”.
Subsec. (c). Pub. L. 114–255, § 2042(e), substituted “Biennial” for “Annual” in heading and “a report on a biennial basis” for “an annual report” in introductory provisions.
Subsec. (c)(6), (7). Pub. L. 114–255, § 2037(b)(1), added pars. (6) and (7).
Subsecs. (d), (e). Pub. L. 114–255, § 2037(b)(2), added subsecs. (d) and (e).
2011—Pub. L. 112–74 amended section generally. Prior to amendment, text read as follows: “The general purpose of the National Center for Research Resources (in this subpart referred to as the ‘Center’) is to strengthen and enhance the research environments of entities engaged in health-related research by developing and supporting essential research resources.”
1993—Pub. L. 103–43 substituted “the National Center for Research Resources (in this subpart referred to as the ‘Center’)” for “the Division of Research Resources”.
Pub. L. 106–505, title III, § 305,